Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: A clinical practice guideline from the American College of Physicians

Annals of Internal Medicine

Volumn 161, Issue 9, 2014, Pages 659-667

  Qaseem, Amir ^a   Dallas, Paul ^b   Forciea, Mary Ann ^c   Starkey, Melissa ^a   Denberg, Thomas D ^d  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CARILION CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CITRIC ACID; MAGNESIUM; MINERAL WATER; TAP WATER; THIAZIDE DIURETIC AGENT; ANTIGOUT AGENT; CALCIUM CHELATING AGENT;

COMPARATIVE EFFECTIVENESS; DIET THERAPY; EMERGENCY WARD; FLUID INTAKE; HIGH FIBER DIET; HOSPITALIZATION; HUMAN; MONOTHERAPY; NEPHROLITHIASIS; PATIENT SAFETY; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PREMEDICATION; PROTEIN INTAKE; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SOFT DRINK; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY TRACT OBSTRUCTION; UROLITHIASIS; ADULT; FLUID THERAPY; PROCEDURES; SECONDARY PREVENTION;

ADULT; ALLOPURINOL; CALCIUM CHELATING AGENTS; CITRIC ACID; FLUID THERAPY; GOUT SUPPRESSANTS; HUMANS; NEPHROLITHIASIS; SECONDARY PREVENTION; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84919394968     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-2908     Document Type: Review

References (58)

1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23. [PMID: 12675858]
2. Pearle MS, Calhoun EA, Curhan GC; Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848-57. [PMID: 15711292]
3. Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111:1006-9. [PMID: 2688503]
4. Attanasio M. The genetic components of idiopathic nephrolithiasis. Pediatr Nephrol. 2011;26:337-46. [PMID: 20563734] doi:10.1007/s00467-010 -1562-6
5. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158:535-43. [PMID: 23546565] doi:10.7326/0003-4819 -158-7-201304020-00005
6. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies. Comparative Effectiveness Review No. 61. (Prepared by the University of Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 12-EHC049-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
7. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010;153:194-9. [PMID: 20679562] doi: 10.7326/0003-4819-153-3-201008030-00010
8. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069-73. [PMID: 9366314]
9. Fernández-Rodríguez A, Arrabal-Martín M, García-Ruiz MJ, Arrabal-Polo MA, Pichardo-Pichardo S, Zuluaga-Gómez A. [The role of thiazides in the prophylaxis of recurrent calcium lithiasis]. Actas Urol Esp. 2006;30:305-9. [PMID: 16749588]
10. Ahlstrand C, Sandwall K, Tiselius HG. Prophylactic treatment of calcium stone formers with hydrochlorothiazide and magnesium. In: HG Tiselius, ed. Renal stones-Aspects on Their Formation, Removal and Prevention. Proceedings of the Sixth European Symposium on Urolithiasis 1995. Edsbruk: Akademitryck; 1995:195-7.
11. Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 1993;22 Suppl 6:S78-86. [PMID: 7508066]
12. Ala-Opas M, Elomaa I, Porkka L, Alfthan O. Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones. Scand J Urol Nephrol. 1987;21:311-4. [PMID: 2832935]
13. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand. 1984;215:383-9. [PMID: 6375276]
14. Scholz D, Schwille PO, Sigel A. Double-blind study with thiazide in recurrent calcium lithiasis. J Urol. 1982;128:903-7. [PMID: 7176047]
15. Lojanapiwat B, Tanthanuch M, Pripathanont C, Ratchanon S, Srinualnad S, Taweemonkongsap T, et al. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Int Braz J Urol. 2011;37:611-6. [PMID: 22099273]
16. Soygür T, Akbay A, Küpeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol. 2002;16: 149-52. [PMID: 12028622]
17. Premgamone A, Sriboonlue P, Disatapornjaroen W, Maskasem S, Sinsupan N, Apinives C. A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health. 2001;32:654-60. [PMID: 11944733]
18. Hofbauer J, Höbarth K, Szabo N, Marberger M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis-a prospective randomized study. Br J Urol. 1994;73:362-5. [PMID: 8199822]
19. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized doubleblind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150:1761-4. [PMID: 8230497]
20. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986; 315:1386-9. [PMID: 3534570]
21. Miano L, Petta S, Galatioto GP, Gullucci M. A placebo controlled doubleblind study of allopurinol in severe recurrent idiopathic renal lithiasis. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, eds. Urolithiasis and Related Clinical Research. New York: Plenum Pr; 1985:521-4.
22. Robertson WG, Peacock M, Sepby PL, Williams RE, Clark P, Chisholm GD, et al. A multicentre trial to evaluate 3 treatments for recurrent idiopathic calcium stone disease-a preliminary report. New York: Plenum Pr; 1985:545-48.
23. Smith MJ. Placebo versus allopurinol for renal calculi. J Urol. 1977;117: 690-2. [PMID: 875139]
24. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23. [PMID: 12675858]
25. Pearle MS, Calhoun EA, Curhan GC; Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848-57. [PMID: 15711292]
26. Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111:1006-9. [PMID: 2688503]
27. Attanasio M. The genetic components of idiopathic nephrolithiasis. Pediatr Nephrol. 2011;26:337-46. [PMID: 20563734] doi:10.1007/s00467-010 -1562-6
28. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158:535-43. [PMID: 23546565] doi:10.7326/0003-4819 -158-7-201304020-00005
29. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies. Comparative Effectiveness Review No. 61. (Prepared by the University of Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 12-EHC049-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
30. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010;153:194-9. [PMID: 20679562] doi: 10.7326/0003-4819-153-3-201008030-00010
31. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069-73. [PMID: 9366314]
32. Fernández-Rodríguez A, Arrabal-Martín M, García-Ruiz MJ, Arrabal-Polo MA, Pichardo-Pichardo S, Zuluaga-Gómez A. [The role of thiazides in the prophylaxis of recurrent calcium lithiasis]. Actas Urol Esp. 2006;30:305-9. [PMID: 16749588]
33. Ahlstrand C, Sandwall K, Tiselius HG. Prophylactic treatment of calcium stone formers with hydrochlorothiazide and magnesium. In: HG Tiselius, ed. Renal stones-Aspects on Their Formation, Removal and Prevention. Proceedings of the Sixth European Symposium on Urolithiasis 1995. Edsbruk: Akademitryck; 1995:195-7.
34. Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 1993;22 Suppl 6:S78-86. [PMID: 7508066]
35. Ala-Opas M, Elomaa I, Porkka L, Alfthan O. Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones. Scand J Urol Nephrol. 1987;21:311-4. [PMID: 2832935]
36. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand. 1984;215:383-9. [PMID: 6375276]
37. Scholz D, Schwille PO, Sigel A. Double-blind study with thiazide in recurrent calcium lithiasis. J Urol. 1982;128:903-7. [PMID: 7176047]
38. Lojanapiwat B, Tanthanuch M, Pripathanont C, Ratchanon S, Srinualnad S, Taweemonkongsap T, et al. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Int Braz J Urol. 2011;37:611-6. [PMID: 22099273]
39. Soygür T, Akbay A, Küpeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol. 2002;16: 149-52. [PMID: 12028622]
40. Premgamone A, Sriboonlue P, Disatapornjaroen W, Maskasem S, Sinsupan N, Apinives C. A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health. 2001;32:654-60. [PMID: 11944733]
41. Hofbauer J, Höbarth K, Szabo N, Marberger M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis-a prospective randomized study. Br J Urol. 1994;73:362-5. [PMID: 8199822]
42. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized doubleblind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150:1761-4. [PMID: 8230497]
43. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986; 315:1386-9. [PMID: 3534570]
44. Miano L, Petta S, Galatioto GP, Gullucci M. A placebo controlled doubleblind study of allopurinol in severe recurrent idiopathic renal lithiasis. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, eds. Urolithiasis and Related Clinical Research. New York: Plenum Pr; 1985:521-4.
45. Robertson WG, Peacock M, Sepby PL, Williams RE, Clark P, Chisholm GD, et al. A multicentre trial to evaluate 3 treatments for recurrent idiopathic calcium stone disease-a preliminary report. New York: Plenum Pr; 1985:545-48.
46. Smith MJ. Placebo versus allopurinol for renal calculi. J Urol. 1977;117: 690-2. [PMID: 875139]
47. Griffith DP, Khonsari F, Skurnick JH, James KE. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. J Urol. 1988;140:318-24. [PMID: 3294442]
48. Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E, Earle N. Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol. 1991;20:243-7. [PMID: 1726639]
49. Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med. 1984;311:760-4. [PMID: 6472365]
50. Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol. 1988;139:679-84. [PMID: 3280829]
51. Dussol B, Iovanna C, Rotily M, Morange S, Leonetti F, Dupuy P, et al. A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract. 2008;110:c185-94. [PMID: 18957869] doi:10.1159/000167271
52. Sarica K, Inal Y, Erturhan S, Yagci F. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res. 2006; 34:184-9. [PMID: 16463053]
53. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77-84. [PMID: 11784873]
54. Di Silverio F, Ricciuti GP, D'Angelo AR, Fraioli A, Simeoni G. Stone recurrence after lithotripsy in patients with recurrent idiopathic calcium urolithiasis: efficacy of treatment with fiuggi water. Eur Urol. 2000;37:145-8. [PMID: 10705191]
55. Kocvara R, Plasgura P, Petrík A, Louzenský G, Bartonícková K, Dvorácek J. A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int. 1999;84:393-8. [PMID: 10468751]
56. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839-43. [PMID: 8583588]
57. Hiatt RA, Ettinger B, Caan B, Quesenberry CP Jr, Duncan D, Citron JT. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol. 1996;144: 25-33. [PMID: 8659482]
58. Shuster J, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992;45:911-6. [PMID: 1624973]